EtoxiClear™, a Chromatography Adsorbent for Effective Removal of Endotoxins from Biopharmaceuticals
EtoxiClear™ is exclusively manufactured by Astrea-Bioseparations, EtoxiClear™ a Chromatography Adsorbent for Effective Removal of Endotoxins.
EtoxiClear™ is designed for use in endotoxin removal applications including process development, sample/buffer preparation steps used during cGMP manufacture of biological molecules.
It is an affinity adsorbent designed for the removal of endotoxin, Endotoxin are lipopolysaccharides (LPS) derived from the cell membrane of Gram-negative bacteria.
-
⮞ Endotoxin elicit a variety of pathophysiological effects and according to the pharmacopoeia the maximum permitted level of endotoxin for intravenous products is 5 EU (endotoxin units) per kg adult per hour.
-
⮞ It is highly stable, robust, and non-toxic, with a high affinity for bacterial endotoxin.
-
⮞ It has Low protein binding and more than 90% recovery.
Following are the Key Features of EtoxiClear™:
-
Cost effective & scalable technology
-
Endotoxin clearance to below 0.1 EU/mg protein
-
Compatible with a wide range of proteins
-
Stable chemical ligand
-
Dynamic binding capacity more than 1,000,000 EU/mL (120 cm/hr., 5 min residence time).